Oct 23, 2020 6:30am EDT ProMIS Neurosciences Announces Up to $3 Million Private Placement Offering of Special Warrants
Oct 21, 2020 6:30am EDT ProMIS Neurosciences Offers its Perspective on the Likelihood of Regulatory Approval of Aducanumab
Oct 13, 2020 6:30am EDT ProMIS Neurosciences’ Neil Cashman to Speak at Protein Misfolding Drug Discovery Conference
Sep 10, 2020 6:30am EDT ProMIS Neurosciences to Participate in H.C. Wainwright & Co. 22nd Annual Investment Conference
Jul 09, 2020 6:30am EDT ProMIS Neurosciences and BC Neuroimmunology announce revenue-sharing joint venture agreement to develop and offer blood-based diagnostic tests for Alzheimer’s disease
Jun 24, 2020 6:30am EDT ProMIS Neurosciences announces adjournment and change of location of annual meeting of shareholders